T. V. Rakitina, A. A. Zeifman, I. Yu. Titov, I. Svitanko, A. V. Lipkin, V. S. Stroylov, O. V. Stroganov, F. N. Novikov, G. G. Chilov, “Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer”, Mendeleev Commun., 22:6 (2012), 287

Mendeleev Communications

RUS ENG

JOURNALS PEOPLE ORGANISATIONS CONFERENCES SEMINARS VIDEO LIBRARY PACKAGE AMSBIB

JavaScript is disabled in your browser. Please switch it on to enable full functionality of the website

	General information
	Latest issue
	Archive

	Search papers
	Search references

	RSS
	Latest issue
	Current issues
	Archive issues
	What is RSS

Mendeleev Commun.:
Year:
Volume:
Issue:
Page:
	Find

Personal entry:
Login:
Password:
	Save password
	Enter
	Forgotten password?
	Register

Mendeleev Communications, 2012, Volume 22, Issue 6, Pages 287–289
DOI: https://doi.org/10.1016/j.mencom.2012.11.001 (Mi mendc2822)

This article is cited in 3 scientific papers (total in 3 papers)

Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer

T. V. Rakitina^ab, A. A. Zeifman^cd, I. Yu. Titov^cd, I. Svitanko^d, A. V. Lipkin^be, V. S. Stroylov^cd, O. V. Stroganov^cd, F. N. Novikov^cd, G. G. Chilov^cd

^a M.M. Shemyakin–Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation
^b National Research Centre 'Kurchatov Institute', Moscow, Russian Federation
^c MolTech Ltd, Moscow, Russian Federation
^d N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation
^e A.N. Bach Institute of Biochemistry, Russian Academy of Sciences, Moscow, Russian Federation

Full-text PDF (348 kB) Citations (3) Supplementary materials

DOI: https://doi.org/10.1016/j.mencom.2012.11.001

Abstract: Novel rationally-designed Syk-kinase inhibitor MT-SYK-03 demonstrated equal potency with R406 (active metabolite of Fostamatinib, a phase III clinical trial candidate) in cellular models of autoimmunity and cancer with EC50 values in sub-micromolar range, while MT-SYK-322 was less active.

Bibliographic databases:

Document Type: Article

Language: English

*Supplementary materials:*
		Supplementary_data_1.pdf	(165.6 Kb)

Citation: T. V. Rakitina, A. A. Zeifman, I. Yu. Titov, I. Svitanko, A. V. Lipkin, V. S. Stroylov, O. V. Stroganov, F. N. Novikov, G. G. Chilov, “Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer”, Mendeleev Commun., 22:6 (2012), 287–289

Linking options:

https://www.mathnet.ru/eng/mendc2822

https://www.mathnet.ru/eng/mendc/v22/i6/p287

This publication is cited in the following 3 articles:

Citing articles in Google Scholar: Russian citations, English citations
Related articles in Google Scholar: Russian articles, English articles

Registration to the website

Logotypes